Updated on 13/07/2026

SAUD3 Odontoprev

Sector: Health CareSubsector: Managed Care
QuoteR$ 15,25
Dividend Yield3,82 %
P/E14,73
P/B5,81

Visno Score

AI-powered fundamental analysis
Powered by AI
Final score
7.6/ 10

Rentabilidade

  • ROE médio dos últimos 5 anos: 39,7%
  • ROIC médio dos últimos 5 anos: 51,3%

Liquidez

  • Liquidez corrente: 1,16x
  • Liquidez seca: 1,16x

Alavancagem

  • Dívida Líquida / EBITDA: 0,00x
  • Dívida Líquida/Patrimônio líquido: 0,00x

Consistência

  • Número de anos consecutivos sem prejuízo: 16 anos
  • Número de anos com lucro nos últimos 10 anos: 10 anos

Crescimento

  • CAGR receita líquida 5 anos: 6,8%

Negociabilidade

  • Porcentagem de ações em circulação: 8,6%
  • Volume diário de negociações: R$ 63,4M/dia

Fundamental Analysis of SAUD3 (Odontoprev)

IA

Odontoprev is a company in the Healthcare sector, operating in the Medical, Hospital, Analysis and Diagnostic Services subsector and segment, with a focus on dental plans. Founded in 1987, it consolidated its position through acquisitions in the dental segment and strategic alliances, offering both corporate and retail services. The company’s shares, traded on B3 under the ticker SAUD3, reflect a business model based on dental health plans, technology, and integration with major sector groups.

Odontoprev’s financial fundamentals indicate high profitability, with gross, net, and EBIT margins at robust levels for a healthcare operator, suggesting operational efficiency and strong pricing power. Revenue and profit growth over five years, while moderate, point to consistent expansion in a more mature market. Virtually zero leverage, with Net Debt/EBITDA at 0.0, combined with current and quick ratios above 1, indicates a comfortable balance sheet position and a conservative financial profile, which must always be interpreted in conjunction with the competitive dynamics of the supplemental healthcare sector.

The company received a 7.6 Visno Score, reflecting a combination of high profitability and low leverage, as well as a consistent track record of results. On the other hand, more moderate scores in growth and tradability call for attention to the pace of expansion and to the liquidity behavior of SAUD3 shares in the market.

AI-generated analysis based on the Visno Score methodology. Data extracted from public financial statements (CVM/B3). Informational content — not investment advice.

SAUD3 Price History

Daily
one_year

SAUD3 Revenue vs. Profit

Anual

Valuation Indicators de SAUD3

Valuation Indicators for SAUD3 — annual indicator history
IndicatorCurrent202520242023202220212020201920182017201620152014201320122011
Price R$ 15,25R$ 11,14R$ 9,94R$ 9,42R$ 7,07R$ 8,71R$ 9,70R$ 10,84R$ 8,64R$ 9,80R$ 7,45R$ 5,43R$ 5,44R$ 5,19R$ 5,46
Price/Earnings (P/E) 14,7310,6411,1313,059,6723,0722,1430,8522,5718,9630,8624,5726,4031,0837,020,00
Price/Book Value (P/B) 5,814,744,694,374,265,936,428,357,249,7010,057,977,987,498,086,36
Dividend Yield 3,82 %8,64 %14,55 %3,89 %4,29 %4,93 %4,74 %3,02 %2,95 %4,88 %4,30 %7,18 %6,84 %6,25 %5,99 %4,04 %
Price/Assets 3,922,722,603,092,413,523,805,154,626,535,074,344,764,905,824,97
Price/EBIT 11,107,948,6710,537,5616,6415,6822,6318,3016,0323,5317,1819,0721,8927,770,00
Price/Net Revenue 3,402,552,723,052,214,904,365,024,775,964,994,104,615,046,120,00
Price/OCF 15,5411,2616,1111,849,276,9356,9632,9219,0832,4033,4419,4019,9825,3028,210,00
Price/FCF 15,7411,3916,5112,019,486,9860,7334,0819,1932,8734,5019,6720,8425,6828,860,00
EV/EBIT 10,407,127,789,967,0415,8113,9421,3617,4215,0822,1116,1218,0920,8626,790,00
EV/EBITDA 9,576,597,179,226,4214,6213,1720,0016,9714,8521,4815,7217,7520,4226,080,00
EV/Net Revenue 3,192,292,442,882,054,663,884,744,545,614,693,854,384,805,910,00
EV/Assets 3,672,442,332,922,253,353,384,864,406,154,774,074,514,675,624,78
EV/OCF 14,5610,1014,4711,198,636,5850,6431,0818,1630,4831,4318,2018,9524,1127,210,00
EV/FCF 14,7510,2214,8311,368,826,6353,9932,1818,2730,9232,4218,4519,7724,4827,850,00
Book Value per Share (BVPS) R$ 2,62R$ 2,36R$ 2,31R$ 2,66R$ 2,12R$ 2,13R$ 2,27R$ 2,02R$ 1,90R$ 1,64R$ 1,25R$ 1,19R$ 1,24R$ 1,31R$ 1,33R$ 4,19
Earnings per Share (EPS) R$ 1,04R$ 1,05R$ 0,98R$ 0,89R$ 0,93R$ 0,55R$ 0,66R$ 0,55R$ 0,61R$ 0,84R$ 0,41R$ 0,38R$ 0,37R$ 0,32R$ 0,29R$ 0,00
Market Cap R$ 8,32 BR$ 6,11 BR$ 6,00 BR$ 6,42 BR$ 5,13 BR$ 6,69 BR$ 7,73 BR$ 8,96 BR$ 7,31 BR$ 8,45 BR$ 6,69 BR$ 5,02 BR$ 5,24 BR$ 5,22 BR$ 5,70 BR$ 4,71 B
Enterprise Value (EV) R$ 7,80 BR$ 5,48 BR$ 5,39 BR$ 6,07 BR$ 4,78 BR$ 6,36 BR$ 6,87 BR$ 8,46 BR$ 6,95 BR$ 7,95 BR$ 6,29 BR$ 4,71 BR$ 4,97 BR$ 4,98 BR$ 5,50 BR$ 4,53 B
Daily Volume R$ 63,39 MR$ 23,83 MR$ 10,77 MR$ 14,75 MR$ 21,31 MR$ 19,13 MR$ 24,69 MR$ 26,70 MR$ 32,00 MR$ 20,06 MR$ 13,77 MR$ 17,28 MR$ 16,64 MR$ 17,07 MR$ 15,83 MR$ 11,06 M

Profitability Indicators de SAUD3

Profitability Indicators for SAUD3 — annual indicator history
IndicatorCurrent202520242023202220212020201920182017201620152014201320122011
Gross Margin 34,83 %35,96 %34,33 %30,90 %61,50 %60,30 %59,60 %55,20 %55,79 %72,51 %50,78 %53,39 %52,53 %53,14 %49,19 %50,14 %
Net Margin 23,09 %24,07 %23,64 %24,14 %23,77 %20,64 %20,46 %15,74 %17,89 %34,99 %15,82 %17,68 %16,84 %17,59 %15,23 %17,40 %
EBIT Margin 30,64 %31,94 %30,13 %30,49 %30,15 %27,57 %29,17 %21,36 %23,97 %40,07 %20,64 %24,70 %23,65 %24,60 %20,92 %21,46 %
ROIC 52,26 %60,29 %55,95 %46,56 %48,38 %45,30 %42,67 %34,60 %36,98 %62,15 %40,38 %47,21 %42,45 %37,70 %28,51 %23,47 %
ROE 39,45 %45,45 %43,92 %36,87 %38,18 %34,09 %30,04 %25,62 %27,72 %54,47 %31,14 %33,91 %30,33 %27,04 %20,79 %19,05 %
ROA 26,59 %29,89 %25,41 %23,63 %22,39 %19,67 %18,80 %16,10 %17,29 %36,19 %15,90 %18,48 %17,66 %17,52 %14,58 %14,63 %
Asset Turnover 1,15 %1,24 %1,07 %0,98 %0,94 %0,95 %0,92 %1,02 %0,97 %1,03 %1,01 %1,05 %1,05 %1,00 %0,96 %0,84 %

Liquidity Indicators de SAUD3

Liquidity Indicators for SAUD3 — annual indicator history
IndicatorCurrent2025202420232022202120202019201820172016201520142013201220112010
Immediate Liquidity 0,030,040,020,020,020,030,060,050,040,040,070,060,050,050,020,050,08
Current Ratio 1,160,800,640,800,700,981,811,641,361,471,891,731,591,681,661,881,35
Quick Ratio 1,160,800,640,800,690,981,811,631,351,461,891,731,581,681,661,871,35
Total Liquidity Ratio 1,631,431,281,581,361,311,511,431,401,761,201,181,201,401,572,032,01

Leverage Indicators de SAUD3

Leverage Indicators for SAUD3 — annual indicator history
IndicatorCurrent2025202420232022202120202019201820172016201520142013201220112010
Net Debt/EBIT 0,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,00
Net Debt/EBITDA 0,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,00
Net Debt/Equity 0,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,00
Gross Debt/Equity 0,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,00
Equity/Assets 0,670,660,580,640,590,580,630,630,620,660,510,540,580,650,700,770,79

Financial Results de SAUD3

Financial Results for SAUD3 — annual indicator history
IndicatorCurrent202520242023202220212020201920182017201620152014201320122011
Net Revenue R$ 2,45 BR$ 2,42 BR$ 2,28 BR$ 2,12 BR$ 1,90 BR$ 1,84 BR$ 1,77 BR$ 1,81 BR$ 1,59 BR$ 1,44 BR$ 1,37 BR$ 1,25 BR$ 1,16 BR$ 1,07 BR$ 955,48 MR$ 835,26 M
Gross Profit R$ 852,33 MR$ 870,29 MR$ 783,05 MR$ 654,73 MR$ 1,17 BR$ 1,11 BR$ 1,05 BR$ 998,56 MR$ 888,12 MR$ 1,04 BR$ 693,24 MR$ 667,16 MR$ 607,28 MR$ 568,44 MR$ 469,95 MR$ 418,80 M
EBITDA R$ 815,14 MR$ 836,20 MR$ 743,38 MR$ 701,88 MR$ 610,61 MR$ 571,53 MR$ 544,82 MR$ 412,81 MR$ 397,55 MR$ 584,08 MR$ 289,19 MR$ 316,41 MR$ 280,22 MR$ 268,23 MR$ 205,09 MR$ 185,46 M
EBIT R$ 749,68 MR$ 773,03 MR$ 687,23 MR$ 646,05 MR$ 573,59 MR$ 507,95 MR$ 514,86 MR$ 386,32 MR$ 381,56 MR$ 575,90 MR$ 281,74 MR$ 308,66 MR$ 273,45 MR$ 263,08 MR$ 199,93 MR$ 179,28 M
Net Profit R$ 564,98 MR$ 582,57 MR$ 539,24 MR$ 511,39 MR$ 452,17 MR$ 380,36 MR$ 361,13 MR$ 284,76 MR$ 284,79 MR$ 502,92 MR$ 215,99 MR$ 220,95 MR$ 194,71 MR$ 188,09 MR$ 145,57 MR$ 145,31 M

Balance Sheet de SAUD3

Balance Sheet for SAUD3 — annual indicator history
IndicatorCurrent2025202420232022202120202019201820172016201520142013201220112010
Assets R$ 2,12 BR$ 1,95 BR$ 2,12 BR$ 2,16 BR$ 2,02 BR$ 1,93 BR$ 1,92 BR$ 1,77 BR$ 1,65 BR$ 1,39 BR$ 1,36 BR$ 1,20 BR$ 1,10 BR$ 1,07 BR$ 998,70 MR$ 993,26 MR$ 912,96 M
Liabilities R$ 692,47 MR$ 667,03 MR$ 894,30 MR$ 776,98 MR$ 835,69 MR$ 818,04 MR$ 718,77 MR$ 657,38 MR$ 620,13 MR$ 466,33 MR$ 664,43 MR$ 544,05 MR$ 460,64 MR$ 378,19 MR$ 298,69 MR$ 230,65 MR$ 194,59 M
Shareholders' Equity R$ 1,43 BR$ 1,28 BR$ 1,23 BR$ 1,39 BR$ 1,18 BR$ 1,12 BR$ 1,20 BR$ 1,11 BR$ 1,03 BR$ 923,24 MR$ 693,58 MR$ 651,60 MR$ 642,03 MR$ 695,70 MR$ 700,01 MR$ 762,61 MR$ 718,37 M
Cash and Equivalents R$ 17,54 MR$ 19,95 MR$ 16,53 MR$ 14,39 MR$ 15,84 MR$ 16,42 MR$ 34,85 MR$ 27,07 MR$ 21,14 MR$ 17,67 MR$ 22,04 MR$ 16,36 MR$ 12,61 MR$ 10,27 MR$ 4,42 MR$ 8,05 MR$ 11,18 M
Inventories R$ 26,00 KR$ 26,00 KR$ 56,00 KR$ 1,42 MR$ 4,77 MR$ 4,42 MR$ 3,88 MR$ 3,44 MR$ 3,11 MR$ 2,99 MR$ 2,02 MR$ 323,00 KR$ 932,00 KR$ 954,00 KR$ 987,00 KR$ 784,00 KR$ 355,00 K
Gross Debt R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00
Net Debt R$ -524,93 MR$ -293,03 MR$ -374,32 MR$ -372,02 MR$ -230,94 MR$ -331,56 MR$ -736,85 MR$ -544,28 MR$ -481,54 MR$ -436,46 MR$ -428,38 MR$ -334,35 MR$ -265,71 MR$ -257,12 MR$ -217,93 MR$ -207,83 MR$ -132,70 M
Short-Term Debt R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00
Long-Term Debt R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00R$ 0,00

Cash Flow de SAUD3

Cash Flow for SAUD3 — annual indicator history
IndicatorCurrent202520242023202220212020201920182017201620152014201320122011
OCF R$ 535,59 MR$ 590,05 MR$ 604,99 MR$ 414,56 MR$ 694,58 MR$ 858,42 MR$ 305,27 MR$ 308,79 MR$ 324,20 MR$ 289,48 MR$ 196,30 MR$ 237,09 MR$ 280,40 MR$ 216,69 MR$ 223,79 MR$ 124,78 M
ICF R$ 116,71 MR$ 99,14 MR$ 9,06 MR$ -233,11 MR$ -355,35 MR$ -446,87 MR$ -32,63 MR$ -38,71 MR$ -201,76 MR$ -15,55 MR$ -27,30 MR$ -17,28 MR$ -22,39 MR$ -19,23 MR$ -10,93 MR$ -10,91 M
Financing CF R$ -656,38 MR$ -685,78 MR$ -611,91 MR$ -182,89 MR$ -339,81 MR$ -429,98 MR$ -264,85 MR$ -264,16 MR$ -118,97 MR$ -278,30 MR$ -163,31 MR$ -216,07 MR$ -255,75 MR$ -191,62 MR$ -216,49 MR$ -117,00 M
CAPEX R$ -6,79 MR$ -6,16 MR$ -10,38 MR$ -7,59 MR$ -8,40 MR$ -5,55 MR$ -9,93 MR$ -11,02 MR$ -4,61 MR$ -3,59 MR$ -4,98 MR$ -5,11 MR$ -10,66 MR$ -2,47 MR$ -3,65 MR$ -4,57 M
FCF R$ 528,80 MR$ 583,89 MR$ 594,60 MR$ 406,96 MR$ 686,18 MR$ 852,87 MR$ 295,34 MR$ 297,77 MR$ 319,59 MR$ 285,89 MR$ 191,32 MR$ 231,98 MR$ 269,74 MR$ 214,22 MR$ 220,14 MR$ 120,21 M

Growth de SAUD3

Growth for SAUD3 — annual indicator history
IndicatorCurrent2025202420232022202120202019201820172016
Net Revenue CAGR 5Y 6,79 %6,51 %4,75 %5,88 %5,77 %6,18 %7,15 %9,37 %8,28 %8,51 %10,32 %
Net Profit CAGR 5Y 7,44 %10,04 %13,62 %12,42 %-2,10 %11,98 %10,33 %7,90 %8,65 %28,14 %8,25 %
EBIT CAGR 5Y 5,81 %8,47 %12,21 %11,11 %-0,08 %12,51 %10,78 %7,16 %7,72 %23,56 %9,46 %
EBITDA CAGR 5Y 6,47 %8,95 %12,48 %12,04 %0,89 %14,60 %11,48 %8,06 %8,19 %23,28 %9,29 %

Target Price de SAUD3

Target Price for SAUD3 — annual indicator history
IndicatorCurrent202520242023202220212020201920182017201620152014201320122011
Target Price - Graham R$ 7,82R$ 7,48R$ 7,13R$ 7,29R$ 6,68R$ 5,11R$ 5,79R$ 4,99R$ 5,10R$ 5,56R$ 3,39R$ 3,20R$ 3,22R$ 3,05R$ 2,94R$ 0,00

Registration Data de SAUD3

Registration Data for SAUD3 — annual indicator history
Sector Health Care
Subsector Managed Care
Website www.odontoprev.com.br/ri
Status Fase Operacional
Years Listed 19
CVM Code 20125
CNPJ 58.119.199/0001-51
Last Price Date 13/07/2026
Last Earnings Date 31/03/2026
Next Earnings Date 03/08/2026
Free Float 8,61 %
Other Tickers N/A

About Odontoprev

Odontoprev S.A. is a private dental care plan operator founded in 1987 by dentistry professionals, initially focused on serving corporate clients seeking dental plans with a higher degree of professionalism, quality, and technology. In 1998, control passed to private equity funds, a move that drove its consolidation in the market and the adoption of corporate governance practices aligned with Brazil’s supplemental healthcare sector. From the late 1990s onward, the company began a continuous acquisition process, incorporating operators such as Unidont, Clidec, DentalCorp, Rede Dental, Care Plus Dental, Sepao, Prontodente, OdontoServ, ADCON, Odonto System, and Mogidonto, among others, which expanded its beneficiary base and regional presence. In 2006, it carried out its initial public offering and became a widely held company, with shares traded on B3 under the ticker ODPV3, listed on the Novo Mercado corporate governance segment.

Odontoprev’s corporate history includes important milestones in partnerships with major groups in the financial and supplemental healthcare sectors. In 2009, it entered into an association agreement with Bradesco Dental, which was later merged, becoming a wholly owned subsidiary of the company until its corporate integration in 2010. In 2010, it signed a memorandum of understanding with BB Seguros Participações and Bradesco Seguros to form a strategic alliance focused on distributing dental plans. In 2013, it structured the joint venture Brasildental Operadora de Planos Odontológicos S.A., in partnership with BB Seguros, for the development and sale of dental plans under the BB Dental brand, with exclusive distribution through Banco do Brasil’s channels for an initial term of 20 years. Also in 2014, Bradesco Saúde came to hold a direct interest equal to 50.01% of Odontoprev’s total share capital, consolidating a reference shareholder from the health insurance sector.

Odontoprev’s core activities are centered on operating, managing, marketing, and providing private dental care plans for both corporate and individual clients. The company is classified by the National Supplemental Health Agency (ANS) as an exclusively dental operator in the tertiary “group dentistry” segment, operating predominantly as a risk manager in employer-sponsored group plans, group affinity plans, and individual and family plans. Its business model is based on monthly per-capita remuneration of beneficiaries and on managing a broad accredited network of dentists, combined with proprietary technology systems for eligibility control, virtual clinical records, auditing, risk management, and quality control. In addition to directly operating plans, the company also holds equity interests in related-service companies, such as software providers for practice management, distributors of dental materials, company-owned clinics, and imaging diagnostics providers.

Odontoprev and its subsidiaries’ products and services are organized into three main plan segments and one group of complementary activities. In prepaid group plans, the company fully assumes the cost of care, plan administration, and oral health management in exchange for a monthly consideration per beneficiary. In postpaid group plans, actuarial risk lies with the corporate client, while Odontoprev provides management, support, and administrative services, receiving a fixed monthly fee and reimbursement of care costs. In prepaid individual plans, it operates similarly to prepaid group plans, but targeting individuals. The business lines are further segmented internally into corporate, SME, and individual, according to portfolio size and beneficiary profile, which guides commercial and pricing strategies. Revenues classified as “other” include dental care at company-owned clinics, administrative and consulting services, distribution of dental materials to the accredited network, development of management software, dental insurance through a subsidiary in Mexico, use of artificial intelligence in clinical auditing, and dental imaging diagnostics.

Odontoprev maintains a diversified corporate structure to support its core dental plan operation. Key subsidiaries and affiliates include Odontoprev Serviços, dedicated to commercial advisory, consulting, and business management; Easy Software, specialized in developing and licensing software for dental offices, clinics, and dental operators; and Dental Partner, focused on wholesale and retail of dental products and equipment, as well as administrative and logistics support services. In the direct provision of healthcare services, Clidec and Boutique Dental stand out for operating networks of company-owned dental clinics, and Grupo Papaiz specializes in dental imaging diagnostics, whose operations were integrated through gradual acquisitions until full control was achieved in 2023. Brasildental, jointly controlled with BB Seguros, operates exclusively dental plans under the BB Dental brand, reinforcing Odontoprev’s presence in the banking channel.

Odontoprev’s geographic presence is nationwide, with an accredited network that, at the end of 2024, comprised around 27,000 dentists distributed across all Brazilian states, proportionally to the beneficiary base. This network is managed by a field consultant structure, supervised by dentists in each region and supported by in-house consultants based at the head office, with strong integration into information systems and CRM and workflow tools. Abroad, the company operates in Mexico through subsidiaries Odontored Seguros Dentales and Oprev Administradora, responsible for the development, operation, management, and marketing of dental care plans and accident and illness insurance, in compliance with local regulations from the Ministry of Health and the National Insurance and Bonding Commission. This international presence broadens its revenue scope, although the main focus remains the Brazilian market.

The regulatory environment is a core element of Odontoprev’s activities. The company is subject to the Private Health Care Plans Law (Law No. 9,656/98) and to ANS oversight, which defines requirements for incorporation, operation, technical reserves, chart of accounts, adjustment criteria, and minimum coverage rules for dental plans. As an exclusively dental operator, Odontoprev registers all its plans with ANS and offers at least the mandatory coverage established in Normative Resolution No. 465. The company is classified in the tertiary dental segment, with less than 10% of care costs incurred in its own network, and is subject to prudential rules that include independent auditing and publication of financial statements. Regulation also defines how monthly premiums may be adjusted: for exclusively dental group plans, adjustments must be communicated to ANS, and for individual plans, they may be tied to official price indices.

In environmental, social, and governance aspects, Odontoprev adopts practices consistent with the less resource-intensive nature of its business model, while paying attention to specific obligations of company-owned clinics and diagnostic units. The company’s dental and radiology facilities follow the guidelines of the National Health Surveillance Agency (ANVISA) and the National Environmental Council (CONAMA) for the generation, handling, and disposal of healthcare service waste, via a Healthcare Waste Management Plan (PGRSS) and sustainability guides shared with its accredited network. The company has a sustainability department responsible for measuring the satisfaction of accredited dentists, beneficiaries, corporate clients, and employees, commissioning research institutes and turning the results into management information for process improvement. In governance, listing on B3’s Novo Mercado under the ticker ODPV3 reinforces the adoption of practices such as share capital composed only of common shares and greater transparency in dealings with the capital markets.

Odontoprev’s commercial strategy combines proprietary distribution channels and partnerships with financial institutions and healthcare operators, enabling access to different customer profiles. The company sells plans through an in-house sales team, a network of independent brokers, alliances with medical-hospital plans, affinity groups, credit card issuers, insurers, as well as through Bradesco and Banco do Brasil channels, e-commerce, and call centers. Partnerships may range from simple joint distribution to models in which Odontoprev assumes the healthcare risk, including co-responsibility contracts with Brasildental and Unimed BH. This multichannel structure seeks to broaden the reach of corporate, SME, and individual dental plans, sustaining the company’s relevance in Brazil’s supplemental dental healthcare segment.

SAUD3 Dividend History

Latest dividends paid by SAUD3 — Dividends and Interest on Equity (JCP)
TypeEx-DateValue per Share
JCP30/06/2026R$ 0,08
JCP18/12/2025R$ 0,05
Dividendo18/12/2025R$ 0,19
JCP18/09/2025R$ 0,05
Dividendo08/08/2025R$ 0,21
JCP24/06/2025R$ 0,05
Dividendo09/05/2025R$ 0,22
Dividendo11/04/2025R$ 0,15
JCP24/03/2025R$ 0,05
JCP20/12/2024R$ 0,04
Dividendo08/11/2024R$ 0,23
JCP01/10/2024R$ 0,03
Dividendo23/08/2024R$ 0,16
JCP24/06/2024R$ 0,04
Dividendo15/05/2024R$ 0,13
Dividendo12/04/2024R$ 0,78
JCP01/04/2024R$ 0,04
JCP18/12/2023R$ 0,04
JCP22/09/2023R$ 0,04
JCP29/06/2023R$ 0,04
Dividendo20/04/2023R$ 0,22
JCP17/03/2023R$ 0,04
JCP15/12/2022R$ 0,03
JCP20/09/2022R$ 0,03
JCP23/06/2022R$ 0,03
Dividendo06/05/2022R$ 0,11
Dividendo04/04/2022R$ 0,08
JCP24/03/2022R$ 0,03
JCP17/12/2021R$ 0,02
JCP22/09/2021R$ 0,03
JCP16/06/2021R$ 0,03
Dividendo19/05/2021R$ 0,18
Dividendo12/04/2021R$ 0,19
JCP16/03/2021R$ 0,02
JCP15/12/2020R$ 0,02
Dividendo03/11/2020R$ 0,14
JCP16/09/2020R$ 0,03
Dividendo11/08/2020R$ 0,16
JCP16/06/2020R$ 0,03
Dividendo05/05/2020R$ 0,04
Dividendo04/05/2020R$ 0,07
JCP17/03/2020R$ 0,03
JCP19/12/2019R$ 0,03
Dividendo04/11/2019R$ 0,04
JCP27/09/2019R$ 0,03
Dividendo06/08/2019R$ 0,05
JCP21/06/2019R$ 0,03
Dividendo07/05/2019R$ 0,10
Dividendo04/04/2019R$ 0,05
JCP21/03/2019R$ 0,03
JCP21/12/2018R$ 0,03
Dividendo21/12/2018R$ 0,11
JCP26/09/2018R$ 0,03
Dividendo30/07/2018R$ 0,05
JCP18/06/2018R$ 0,03
Dividendo05/04/2018R$ 0,01
JCP15/03/2018R$ 0,03
JCP14/12/2017R$ 0,02
Dividendo30/10/2017R$ 0,10
JCP21/09/2017R$ 0,02
Dividendo31/07/2017R$ 0,19
JCP22/06/2017R$ 0,02
Dividendo02/05/2017R$ 0,08
Dividendo31/03/2017R$ 0,07
JCP20/03/2017R$ 0,02
JCP16/12/2016R$ 0,02
Dividendo31/10/2016R$ 0,05
JCP20/09/2016R$ 0,02
Dividendo01/08/2016R$ 0,04
JCP17/06/2016R$ 0,02
Dividendo27/04/2016R$ 0,08
Dividendo12/04/2016R$ 0,09
JCP14/03/2016R$ 0,02
JCP15/12/2015R$ 0,02
Dividendo29/10/2015R$ 0,06
JCP16/09/2015R$ 0,02
Dividendo29/07/2015R$ 0,08
JCP11/06/2015R$ 0,02
Dividendo30/04/2015R$ 0,11
Dividendo07/04/2015R$ 0,10
JCP13/03/2015R$ 0,01
JCP16/12/2014R$ 0,01
Dividendo28/10/2014R$ 0,07
JCP18/09/2014R$ 0,01
Dividendo29/07/2014R$ 0,07
JCP25/06/2014R$ 0,02
Dividendo29/04/2014R$ 0,09
Dividendo02/04/2014R$ 0,11
JCP28/03/2014R$ 0,02
JCP20/12/2013R$ 0,01
JCP29/10/2013R$ 0,02
Dividendo29/10/2013R$ 0,06
Dividendo30/07/2013R$ 0,06
JCP25/06/2013R$ 0,02
Dividendo30/04/2013R$ 0,09
Dividendo02/04/2013R$ 0,08
JCP26/03/2013R$ 0,02
Dividendo25/10/2012R$ 0,05
JCP25/10/2012R$ 0,02
Dividendo27/07/2012R$ 0,06
JCP27/07/2012R$ 0,02
Dividendo27/04/2012R$ 0,05
JCP27/04/2012R$ 0,03
Dividendo02/04/2012R$ 0,41
JCP26/12/2011R$ 0,10
JCP11/08/2011R$ 0,13
Dividendo11/08/2011R$ 0,27
Dividendo15/04/2011R$ 0,09
Dividendo10/11/2010R$ 0,32
JCP10/11/2010R$ 0,18
Restituição25/05/2010R$ 5,60
Restituição01/03/2010R$ 4,58
Dividendo23/12/2009R$ 2,90
JCP13/08/2009R$ 0,40
Dividendo27/04/2009R$ 0,57
JCP18/12/2008R$ 0,05
JCP18/11/2008R$ 0,19
JCP07/08/2008R$ 0,32
JCP20/12/2007R$ 0,23
Dividendo09/08/2007R$ 0,16
JCP09/08/2007R$ 0,25
Dividendo19/04/2007R$ 0,32

Find new opportunities

Discover stocks with the best fundamentals

SAUD3 indicator guide

What is SAUD3's current price?

What is SAUD3's Price today?

SAUD3's Price is R$ 15,25 (13/07/2026).

What is Price and what does it indicate?

The stock's latest market price, representing the value at which it traded at the most recent close.

How should SAUD3's Price be interpreted?

Price changes reflect shifts in market expectations; monitoring them alongside other indicators helps identify opportunities and risks.

What can affect SAUD3's Price?

It is influenced by the company's financial performance, market news, macroeconomic conditions, and investor sentiment.

SAUD3's P/E: is the stock expensive or cheap?

What is SAUD3's Price/Earnings (P/E) today?

SAUD3's Price/Earnings (P/E) is 14,73 (13/07/2026).

What is Price/Earnings (P/E) and what does it indicate?

Price/Earnings relates the stock's market price to earnings per share, showing how much investors are willing to pay for the company's earnings.

How should SAUD3's Price/Earnings (P/E) be interpreted?

A high P/E generally suggests strong expectations for future growth, while a low P/E may indicate an undervalued stock or operating challenges.

What can affect SAUD3's Price/Earnings (P/E)?

This indicator is influenced by operating results, earnings growth, macroeconomic conditions, and investor expectations, and varies across the economic cycle.

SAUD3's P/B: what it reveals about valuation

What is SAUD3's Price/Book Value (P/B) today?

SAUD3's Price/Book Value (P/B) is 5,81 (13/07/2026).

What is Price/Book Value (P/B) and what does it indicate?

Price/Book Value per Share relates the stock's market price to book value per share, showing how much investors pay for the company's equity.

How should SAUD3's Price/Book Value (P/B) be interpreted?

A P/B below 1 may signal an undervalued stock, while a high value may reflect expectations of future appreciation or risks related to asset quality.

What can affect SAUD3's Price/Book Value (P/B)?

Capital structure, the share of intangible assets, reinvestment policies, and economic conditions significantly affect book value.

SAUD3's Dividend Yield: how much does it pay in dividends?

What is SAUD3's Dividend Yield today?

SAUD3's Dividend Yield is 3,82 % (13/07/2026).

What is Dividend Yield and what does it indicate?

Dividend Yield is the percentage relationship between dividends paid to shareholders and the current stock price, showing the return received as dividends.

How should SAUD3's Dividend Yield be interpreted?

A high Dividend Yield may indicate an income opportunity, but it should be assessed alongside earnings stability and the consistency of dividend distributions over time.

What can affect SAUD3's Dividend Yield?

The company's dividend policy, financial results, cash flow, and capital allocation strategies are key drivers of Dividend Yield.

SAUD3's EV/EBITDA: valuation accounting for debt

What is SAUD3's EV/EBITDA today?

SAUD3's EV/EBITDA is 9,57 (13/07/2026).

What is EV/EBITDA and what does it indicate?

EV/EBITDA relates enterprise value to EBITDA, highlighting operating cash-generation capacity before depreciation and amortization.

How should SAUD3's EV/EBITDA be interpreted?

A low value may suggest an attractive valuation, while a high value may indicate an expensive valuation or weak operating cash generation.

What can affect SAUD3's EV/EBITDA?

Depreciation policies, investments, and operating efficiency influence EBITDA.

SAUD3's BVPS: what is the book value per share?

What is SAUD3's Book Value per Share (BVPS) today?

SAUD3's Book Value per Share (BVPS) is R$ 2,62 (13/07/2026).

What is Book Value per Share (BVPS) and what does it indicate?

Book Value per Share is the accounting value assigned to each share, reflecting the company's equity on a per-share basis.

How should SAUD3's Book Value per Share (BVPS) be interpreted?

A low Book Value per Share may indicate an undervalued stock, while a high value may suggest the stock is expensive on an accounting basis.

What can affect SAUD3's Book Value per Share (BVPS)?

Asset revaluations, retained earnings, and dividend policies influence Book Value per Share.

SAUD3's EPS: how much profit per share?

What is SAUD3's Earnings per Share (EPS) today?

SAUD3's Earnings per Share (EPS) is R$ 1,04 (13/07/2026).

What is Earnings per Share (EPS) and what does it indicate?

Earnings per Share is net income divided by the total number of shares, indicating the earnings attributable to each share.

How should SAUD3's Earnings per Share (EPS) be interpreted?

Rising Earnings per Share is a positive profitability signal, while a decline may indicate challenges in generating earnings.

What can affect SAUD3's Earnings per Share (EPS)?

Operating efficiency, cost management, and changes in net income influence Earnings per Share.

SAUD3's Market Cap: how much is the company worth on the exchange?

What is SAUD3's Market Cap today?

SAUD3's Market Cap is R$ 8,32 B (13/07/2026).

What is Market Cap and what does it indicate?

Market capitalization is the company's total market value, calculated by multiplying the share price by the number of shares outstanding.

How should SAUD3's Market Cap be interpreted?

A high market capitalization may indicate an established company, while a low value may point to growth opportunities or greater volatility.

What can affect SAUD3's Market Cap?

Share price, share count, and market conditions influence market capitalization.

SAUD3's Net Margin: how much profit is left per dollar sold?

What is SAUD3's Net Margin today?

SAUD3's Net Margin is 23,09 % (13/07/2026).

What is Net Margin and what does it indicate?

Net Margin is net income as a percentage of net revenue, showing the company's effective profitability.

How should SAUD3's Net Margin be interpreted?

High margins indicate efficient conversion of revenue into profit, while low margins may signal challenges.

What can affect SAUD3's Net Margin?

Cost management, operating expenses, and the tax burden influence Net Margin.

SAUD3's ROIC: the return on invested capital

What is SAUD3's ROIC today?

SAUD3's ROIC is 52,26 % (13/07/2026).

What is ROIC and what does it indicate?

ROIC (Return on Invested Capital) measures the return earned on all capital invested in the company, reflecting how efficiently resources are used.

How should SAUD3's ROIC be interpreted?

A high ROIC suggests efficient use of resources, while a low ROIC may indicate inefficient capital allocation.

What can affect SAUD3's ROIC?

Investment strategies, operating efficiency, and capital structure influence ROIC.

SAUD3's ROE: is the company efficient at generating profit?

What is SAUD3's ROE today?

SAUD3's ROE is 39,45 % (13/07/2026).

What is ROE and what does it indicate?

ROE (Return on Equity) measures the return on shareholders' equity, reflecting profitability for shareholders.

How should SAUD3's ROE be interpreted?

A high ROE is generally positive, but it should be assessed together with the company's capital structure.

What can affect SAUD3's ROE?

Operating management, dividend policy, and financial leverage influence ROE.

SAUD3's Net Debt/EBITDA: is the debt level healthy?

What is SAUD3's Net Debt/EBITDA today?

SAUD3's Net Debt/EBITDA is 0,00 (13/07/2026).

What is Net Debt/EBITDA and what does it indicate?

Net Debt/EBITDA assesses the company's ability to repay debt with cash generated by operations, before depreciation and amortization.

How should SAUD3's Net Debt/EBITDA be interpreted?

Low values indicate greater financial safety, while high values may signal excessive debt risk.

What can affect SAUD3's Net Debt/EBITDA?

Capital structure, operating efficiency, and investments influence EBITDA.

Frequently Asked Questions about SAUD3

What is SAUD3's stock price today?

SAUD3's price on 13/07/2026 is R$ 15.25. The price is updated based on the latest data available from B3.

Does SAUD3 pay dividends?

Over the last 12 months, SAUD3 paid dividends and/or JCP in June, August, September, and December, totaling R$ 0.58 per share (Dividend Yield of 3.82%). Payments depend on results and decisions made by the board of directors.

How do I buy SAUD3 shares?

To buy SAUD3 (Odontoprev) shares, you need an account with a brokerage that has access to B3. After that, just search for the ticker SAUD3 and place a buy order through the brokerage's platform.

How do I analyze SAUD3 stock?

To analyze SAUD3, consider indicators such as P/E of 14.73, Dividend Yield of 3.82%, ROE of 39.45%, net margin of 23.09%. The evaluation should include comparison with companies in the same sector and the company's financial history.